2026 Kia EV9 Recognized as Cars.Com Top 3Row EV Pick
EV9 took top honors as “Top Pick: 3-Row Electric SUV”Second consecutive year…
CCCC Lisbon 2025 Announces Bybit EU and Top Partners as Sponsors of Its Third Global Edition
LISBON, Portugal, Sept. 29, 2025 /PRNewswire/ -- The Crypto Content Creator Campus…
InboxAlly to Showcase Inbox-First Deliverability at LeadsCon Connect 2025 in Chicago
September 29, 2025 10:00 ET | Source: InboxAlly New York, NY, Sept.…
Fynd Enters GCC to Power the Region’s Next Wave of Retail Innovation
Fynd opens its first international office in the GCC, establishing its Middle…
Patients Taking AUSTEDO XR (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction
Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94%…
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed
Through Week 56 in the SOLARIS trial, there were no suspected or…
Novo Nordisks oral semaglutide 25 mg (Wegovy in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study
Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy®) achieved significant…
TokenFi Sponsors Englands T20 Matches
Wednesday 17 September, 2025 TokenFi Partners with England tour of Ireland 2025…
World’s Largest Toy, Baby, Licensing & Preschool Expo: Connecting Integrated Sourcing Under One Roof
SHANGHAI, Sept. 16, 2025 /PRNewswire/ -- 2025 China Toy Expo (CTE), China…
People taking Novo Nordisks Wegovy experienced reduced food noise and boosted mental well-being
Results from a real-world survey suggest that semaglutide for weight management (Wegovy®)…